435 related articles for article (PubMed ID: 17200430)
1. Prevention of postoperative nausea and vomiting.
Wilhelm SM; Dehoorne-Smith ML; Kale-Pradhan PB
Ann Pharmacother; 2007 Jan; 41(1):68-78. PubMed ID: 17200430
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies.
Kovac AL
Ann Pharmacother; 2006 May; 40(5):873-87. PubMed ID: 16670361
[TBL] [Abstract][Full Text] [Related]
3. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting.
Loewen PS; Marra CA; Zed PJ
Can J Anaesth; 2000 Oct; 47(10):1008-18. PubMed ID: 11032279
[TBL] [Abstract][Full Text] [Related]
4. [Postoperative nausea and vomiting--pathophysiology, prophylaxis and treatment].
Lipka F; Wappler F; Leuwer R; Schulte Am Esch J
Laryngorhinootologie; 2002 Oct; 81(10):725-31. PubMed ID: 12397523
[TBL] [Abstract][Full Text] [Related]
5. [Postoperative nausea and vomiting: cost and therapeutic algorithm. Part II: high-risk patients and late PONV].
Odin I; Merle JC; Feiss P; Nathan N
Ann Fr Anesth Reanim; 2004 Jun; 23(6):581-8. PubMed ID: 15234723
[TBL] [Abstract][Full Text] [Related]
6. [Postoperative nausea and vomiting: rational algorithms for prevention and treatment based on current evidence].
Kranke P; Eberhart LH
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):286-94; quiz 295. PubMed ID: 19367533
[TBL] [Abstract][Full Text] [Related]
7. The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients.
White PF; O'Hara JF; Roberson CR; Wender RH; Candiotti KA;
Anesth Analg; 2008 Aug; 107(2):452-8. PubMed ID: 18633023
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists.
Kovac AL
J Clin Anesth; 2006 Jun; 18(4):304-18. PubMed ID: 16797435
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV.
Leslie JB; Gan TJ
Ann Pharmacother; 2006 May; 40(5):856-72. PubMed ID: 16670360
[TBL] [Abstract][Full Text] [Related]
10. Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis.
Habib AS; Chen YT; Taguchi A; Hu XH; Gan TJ
Curr Med Res Opin; 2006 Jun; 22(6):1093-9. PubMed ID: 16846542
[TBL] [Abstract][Full Text] [Related]
11. The relationship between patient risk factors and early versus late postoperative emetic symptoms.
White PF; Sacan O; Nuangchamnong N; Sun T; Eng MR
Anesth Analg; 2008 Aug; 107(2):459-63. PubMed ID: 18633024
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV.
Pellegrini J; DeLoge J; Bennett J; Kelly J
AANA J; 2009 Aug; 77(4):293-9. PubMed ID: 19731848
[TBL] [Abstract][Full Text] [Related]
13. Postoperative nausea and vomiting: a review of current literature.
Ku CM; Ong BC
Singapore Med J; 2003 Jul; 44(7):366-74. PubMed ID: 14620731
[TBL] [Abstract][Full Text] [Related]
14. Antiemetic prophylaxis: pharmacology and therapeutics.
Norred CL
AANA J; 2003 Apr; 71(2):133-40. PubMed ID: 12776642
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative nausea and vomiting after neurosurgery (infratentorial and supratentorial surgery)].
Audibert G; Vial V
Ann Fr Anesth Reanim; 2004 Apr; 23(4):422-7. PubMed ID: 15120791
[TBL] [Abstract][Full Text] [Related]
17. The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron.
Jones S; Strobl R; Crosby D; Burkard JF; Maye J; Pellegrini JE
AANA J; 2006 Apr; 74(2):127-32. PubMed ID: 16617916
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic antiemetics in oral and maxillofacial surgery: a requiem?
Alexander M; Krishnan B; Yuvraj V
J Oral Maxillofac Surg; 2009 Sep; 67(9):1873-7. PubMed ID: 19686923
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative nausea and vomiting. Identification of patients with risk factors for PONV].
Eberhart LH; Kranke P
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):280-4; quiz 285. PubMed ID: 19367532
[TBL] [Abstract][Full Text] [Related]
20. Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials.
Eberhart LH; Morin AM; Bothner U; Georgieff M
Acta Anaesthesiol Scand; 2000 Nov; 44(10):1252-7. PubMed ID: 11065206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
